Curcumin is the active ingredient in Turmeric, the yellow powder that is ground from the rhizome (looks similar to Ginger) of the turmeric plant.
In this video, Dr. James Meschino discusses how curcumin helps reduce the risk.
- Many natural agents that show evidence of reducing cancer risks in animal studies, but few have been tested in human trials.
- Curcumin is an exception that has been tested in humans.
- Curcumin has multimodal cancer-prevention properties (it affects cancer risks on many levels).
- Reduces the effect of EDGF receptors in breast, prostate and colon cancer. These receptors are responsible for accelerating cell division. Curcumin tones these receptor down reducing the risk of cancer.
- Curcumin blocks COX enzyme (aspirin blocks this enzyme) that blocks the formation of prostaglandins series 2 (PG-2) which causes cells to divide too fast.
- There is also an enzyme that causes the conversion of some fats into prostaglandins that cause the cells to divide too quickly. Curcumin blocks this enzyme (aspirin doesn’t).
- Curcumin blocks the formation of new blood vessels to tumors.
- It’s also non-toxic.
- In a human study with high risk patients, polyps shrunk by 60% and 60% fewer polyps in a 6 month period. No drugs can do this yet.